Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "AML"

714 News Found

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


BD, Suttons Creek partner to streamline combination product development
R&D | April 30, 2026

BD, Suttons Creek partner to streamline combination product development

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration


Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
R&D | April 24, 2026

Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples

Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance


PharmEasy integrates with Samsung Health to streamline digital healthcare
Digitisation | February 23, 2026

PharmEasy integrates with Samsung Health to streamline digital healthcare

Samsung Health users can now order medicines, book lab tests and online consultations through PharmEasy, along with 6 months of complimentary PharmEasy Plus membership


Sanofi’s Amlitelimab delivers in Phase 3 trials, heads for global filings
Clinical Trials | January 28, 2026

Sanofi’s Amlitelimab delivers in Phase 3 trials, heads for global filings

In the SHORE phase 3 study, amlitelimab, used in combination with topical therapies, met all primary and key secondary endpoints at Week 24


AVEO Oncology doses first patient in pioneering AML clinical trial
Clinical Trials | January 16, 2026

AVEO Oncology doses first patient in pioneering AML clinical trial

The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy


EMA launches streamlined process to fast-track critical medicines, vaccines
News | November 21, 2025

EMA launches streamlined process to fast-track critical medicines, vaccines

The move is expected to be crucial during health crises


Alembic and Amlan launch feed additive solutions for poultry
News | October 07, 2025

Alembic and Amlan launch feed additive solutions for poultry

These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~